Pharma Mega-Mergers, Rise and Shein 1/9/24

Pharmaceutical giants are shelling out billions of dollars lately to buy promising new drugs. Is this a sign of good financial health, or a problem with pipelines? We’ll discuss. Plus, there’s more and more data coming out on Shein as it prepares for a U.S. IPO. We’ll break down it’s revenue numbers, and where it ranks compared to American retailers.